3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
8
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Resectable Esophageal Cancer
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Interventions
Magnetic Resonance Spectroscopy
8
X-Rays
7
Phantoms, Imaging
7
Cyclophosphamide
7
Specimen Handling
6
Nuclear Medicine Department, Hospital
5
fludarabine
4
Etoposide
4
Biopsy
4
tazemetostat
3
etoposide phosphate
3
Vincristine
3
Temozolomide
3
Nivolumab
3
Cisplatin
3
Carboplatin
3
Automobiles
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Topotecan
2
Sirolimus
2
Methotrexate
2
Mesna
2
LY3023414
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Colony-Stimulating Factors
×
1 year
×
Clear all
No trials found.